Combination Therapy with Methylprednisolone and Brain Derived Neurotrophic Factor Promotes Remyelination and Functional Recovery Following Spinal Cord Injury in Rats

李立新,付震,胡卫星,顾培元,吴幼章,徐启武
DOI: https://doi.org/10.3760/j:issn:1001-8050.2002.07.012
2002-01-01
Chinese Journal of Traumatology
Abstract:Objective To investigate the effects of combination therapy with methylprednisolone (MP) and brain derived neurotrophic factor (BDNF) on remylination and neurological recovery of function after spinal cord injury in rats. Methods Contusion injury to rat spinal cord was produced at T 10 vertebra level. Twenty eight rats were randomly divided into two groups: Group A received MP and BDNF; Group B received MP and CSF. The spinal cord neurofunctional recovery was observed by using RT PCR, immunohistochemical method and BBB. Results One day after therapy, PLP mRNA expression in the Group A resulted in a 45.3% increase compared with that in the Group B ( P 0.05). The expressions of LFB and MBP positive myelin in the Group A were increased twice more than that in the Group B 10 weeks later ( P 0.05). The neurofunctional recovery was in a good condition in the Group A. Conclusions Combination therapy with MP and BDNF promotes significantly remyelination and functional recovery following spinal cord injury and is an effective approach to treatment of spinal cord injury.
What problem does this paper attempt to address?